158 related articles for article (PubMed ID: 2725060)
21. Early expression of MCS2 (CD13) in the cytoplasm of blast cells from acute myeloid leukaemia.
Pombo de Oliveira MS; Matutes E; Rani S; Morilla R; Catovsky D
Acta Haematol; 1988; 80(2):61-4. PubMed ID: 2901804
[TBL] [Abstract][Full Text] [Related]
22. Monoclonal antibodies against human myelomonocytic cells: detection of certain lineage-specific antigens on CFU-GM progenitor cells.
Takaishi M; Fu SM
J Immunol; 1985 Aug; 135(2):1523-9. PubMed ID: 2409154
[TBL] [Abstract][Full Text] [Related]
23. Characteristics of a monoclonal antibody (RM124) against acute myelocytic leukemia cells.
Martens AC; Johnson RJ; Kaizer H; Hagenbeek A
Exp Hematol; 1984 Sep; 12(8):667-71. PubMed ID: 6386506
[TBL] [Abstract][Full Text] [Related]
24. T lymphoid/myeloid bilineal crisis in chronic myelogenous leukemia.
Akashi K; Mizuno S; Harada M; Kimura N; Kinjyo M; Shibuya T; Shimoda K; Takeshita M; Okamura S; Matsumoto I
Exp Hematol; 1993 Jun; 21(6):743-8. PubMed ID: 7684698
[TBL] [Abstract][Full Text] [Related]
25. The expression of mature myeloid cell differentiation markers in acute leukemia.
White DL; Ashman LK; Dart GW; Zola H; Toogood IR; Kimber RJ
Pathology; 1987 Apr; 19(2):137-42. PubMed ID: 3483338
[TBL] [Abstract][Full Text] [Related]
26. Leu-M1 antigen as a marker of acute nonlymphoid leukemia.
Chan J; Beckstead JH
Hematol Pathol; 1987; 1(4):209-15. PubMed ID: 2461928
[TBL] [Abstract][Full Text] [Related]
27. Anti-CD33 monoclonal antibody M195 for the therapy of myeloid leukemia.
Caron PC; Scheinberg DA
Leuk Lymphoma; 1993; 11 Suppl 2():1-6. PubMed ID: 8124221
[TBL] [Abstract][Full Text] [Related]
28. The product of the proto-oncogene c-kit (P145c-kit) is a human bone marrow surface antigen of hemopoietic precursor cells which is expressed on a subset of acute non-lymphoblastic leukemic cells.
Bühring HJ; Ullrich A; Schaudt K; Müller CA; Busch FW
Leukemia; 1991 Oct; 5(10):854-60. PubMed ID: 1720490
[TBL] [Abstract][Full Text] [Related]
29. [Immunologic phenotype of blast cells in the diagnosis of myeloblastic leukemias].
Baryshnikov AIu; Volkova MA; Frenkel' MA; Tupitsyn NN; Morozova LF
Ter Arkh; 1985; 57(5):98-100. PubMed ID: 3895550
[TBL] [Abstract][Full Text] [Related]
30. CD33 detection by immunohistochemistry in paraffin-embedded tissues: a new antibody shows excellent specificity and sensitivity for cells of myelomonocytic lineage.
Hoyer JD; Grogg KL; Hanson CA; Gamez JD; Dogan A
Am J Clin Pathol; 2008 Feb; 129(2):316-23. PubMed ID: 18208813
[TBL] [Abstract][Full Text] [Related]
31. 013 (CD99) positivity in hematologic proliferations correlates with TdT positivity.
Robertson PB; Neiman RS; Worapongpaiboon S; John K; Orazi A
Mod Pathol; 1997 Apr; 10(4):277-82. PubMed ID: 9110287
[TBL] [Abstract][Full Text] [Related]
32. Immunophenotypic characterisation of monocytoid differentiation markers in acute non-lymphoblastic leukaemias.
Liu TC; Tan GB; Wong CL; Han P
Ann Acad Med Singap; 1991 May; 20(3):353-5. PubMed ID: 1929178
[TBL] [Abstract][Full Text] [Related]
33. A novel monoclonal antibody, KOR-SA3544 which reacts to Philadelphia chromosome-positive acute lymphoblastic leukemia cells with high sensitivity.
Mori T; Sugita K; Suzuki T; Okazaki T; Manabe A; Hosoya R; Mizutani S; Kinoshita A; Nakazawa S
Leukemia; 1995 Jul; 9(7):1233-9. PubMed ID: 7543176
[TBL] [Abstract][Full Text] [Related]
34. "Pan-myeloid" reagent: the monoclonal antibody MCS-2 in the routine immunodiagnostic service of leukemia phenotyping.
Drexler HG; Sagawa K; Menon M; Minowada J
Jpn J Cancer Res; 1985 Mar; 76(3):235-9. PubMed ID: 3922842
[TBL] [Abstract][Full Text] [Related]
35. Expression of myeloid differentiation antigens in acute nonlymphocytic leukemia: increased concentration of CD33 antigen predicts poor outcome--a report from the Childrens Cancer Study Group.
Dinndorf PA; Buckley JD; Nesbit ME; Lampkin BC; Piomelli S; Feig SA; Kersey JH; Hammond GD; Bernstein ID
Med Pediatr Oncol; 1992; 20(3):192-200. PubMed ID: 1574028
[TBL] [Abstract][Full Text] [Related]
36. An antigen shared by human granulocytes, monocytes, marrow granulocyte precursors and leukemic blasts.
Shumak KH; Rachkewich RA
Acta Haematol; 1983; 69(3):164-70. PubMed ID: 6404099
[TBL] [Abstract][Full Text] [Related]
37. Characterization of murine and humanized anti-CD33, gelonin immunotoxins reactive against myeloid leukemias.
McGraw KJ; Rosenblum MG; Cheung L; Scheinberg DA
Cancer Immunol Immunother; 1994 Dec; 39(6):367-74. PubMed ID: 8001024
[TBL] [Abstract][Full Text] [Related]
38. Determination of myeloid antigen expression on childhood acute lymphoblastic leukaemia cells: discrepancies using different monoclonal antibody clones.
Firat H; Favier R; Adam M; Leverger G; Landman-Parker J; Cayre Y; Douay L
Leuk Lymphoma; 2001 Jun; 42(1-2):75-82. PubMed ID: 11699224
[TBL] [Abstract][Full Text] [Related]
39. Diversity of acute non-lymphocytic leukemia analyzed with monoclonal antibodies reactive with myeloid differentiation antigens.
Morishima Y; Morishita Y; Okumura M; Minami S; Ohno R
Jpn J Clin Oncol; 1986 Mar; 16(1):49-57. PubMed ID: 3702071
[TBL] [Abstract][Full Text] [Related]
40. Monoclonal antibodies raised against K562 cells reacted with human haematopoietic pluripotent stem cells.
Kubota Y; Tanaka T; Irino S
Leuk Res; 1991; 15(4):195-204. PubMed ID: 2030600
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
